Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000634579 | SCV000755909 | pathogenic | 3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency | 2024-01-11 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Arg103*) in the SRD5A2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SRD5A2 are known to be pathogenic (PMID: 1406794, 1944596). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This premature translational stop signal has been observed in individual(s) with steroid-5 alpha-reductase deficiency (PMID: 11869378, 22876553). ClinVar contains an entry for this variant (Variation ID: 74593). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. |
Clinical Genetics and Genomics, |
RCV001270012 | SCV001450429 | pathogenic | not provided | 2019-06-05 | criteria provided, single submitter | clinical testing |